Cord Blood Banking Market Size By Type of Bank (Public, Private), By Services (Processing, Storage), By Application (Cancer, Blood Disorders, Immuno-deficiency Disorders, Metabolic Disorders, Bone Marrow Failure Syndrome), By End-use (Hospitals, Research Institutes, Specialty Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Apr 2019  |  Report ID: GMI3268  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 161   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Cord Blood Banking Market size was over USD 16 billion in 2018 and is expected to witness more than 5% CAGR from 2019 to 2025.

Cord Blood Banking Market
Get more details on this report - Request Free Sample PDF

Growing prevalence of genetic disorders such as sickle cell anemia, thalassemia, cystic fibrosis, Tay-Sachs disease, haemophilia, fragile X syndrome and Huntington's disease are the primary factor for the growth of cord blood banking market. As per the WHO estimates, about 2 million people in the U.S. are predicted to carry sickle cell allele. Rising burden of genetic disorders will enhance the demand for cord blood transplantations in the future.

Increasing awareness pertaining to various therapeutic applications of cord blood cells will serve as high impact rendering factor. Numerous government and private organizations are involved in creating awareness regarding numerous advantages of preservation of cord blood.

By Type of Bank

Germany cord blood banking market

Get more details on this report - Request Free Sample PDF

Private cord blood banking market valued at USD 13.7 billion in 2018 owing to growing awareness among expectant parents as well as high demand to safeguard the health of family members by storing and preserving precious cord blood stem cells. Factors such as sufficient supply of cord blood along with guarantee for the availability of cells for transplantation in multiple relatives further will boost segment growth.

Public cord blood banks will showcase growth rate of 6.1% till 2025 led by increase in the number and diversity of cord blood units available for patients and strong support from the federal and private funding. Moreover, public banks are the primary source of cord blood cells for research professionals to investigate novel and potentially life-saving therapies for the patient population.

By Services

Processing service in the cord blood banking market accounted for USD 12.6 billion in 2018 impelled by various technological advancements in cord blood processing methods. For instance, PrepaCyte-CB is a premium processing method of Cryo-Cell that provides better separation along with less crossover of the red and white cells. Contamination of red blood cells can be toxic and may lead to loss of precious cord blood cells during freezing. Removal of RBCs require processing, thus leading to the segment expansion during the forecast period.

Storage service segment is estimated to attain a CAGR of 5.6% through 2025 propelled by increasing number of expectant parents availing preservation of the new-born’s cord blood cells. Various offers and discounts give by private cord blood banks for long-term storage of cord blood cells of infants will significantly drive the storage services in the future.

By Application

Cord blood banking market for immuno-deficiency disorders is poised to expand at more than 5.6% CAGR during 2019 to 2025. Cord blood cells are increasingly being used for the treatment of primary immuno-deficiency disorders. Factors such as rapid and reliable recovery of immune function, low risk of graft versus host disease, and low viral transmission rate will influence the growth of market for immuno-deficiency disorders treatment. Government organizations are constantly providing funds along with spreading awareness related to stem cell transplants thus fostering the segment demand.

Metabolic disorders segment crossed USD 1.9 billion in 2018. Rising incidence of various metabolic disorders such as Krabbe leukodystrophy, Gunther Disease, Tay-Sachs disease will augment the application of cord blood cells for treatment of metabolic disorders. Cord blood cells are less reactive and more adaptable once they enter the patient’s body. Cord blood stem cell transplantation is the only effective treatment for the ailment in mildly affected late-onset patients and pre-symptomatic infantile patients.

By End-use

Hospitals end-use segment in the cord blood banking market revenue was around USD 9.4 billion in 2018. Hospitals have a complete transplantation set up with latest technology and a highly experienced and qualified healthcare personnel. Furthermore, advancements in the field of cord blood banking and its growing popularity will consequently increase the application of cord blood transplantations in the near future. Increasing prevalence of genetic diseases and cancer around the globe is driving the hospitals segment for cord blood treatment.

Specialty clinics segment held 21.9% of the cord blood banking market share in 2018 due to increasing technological advancements that improve the quality of treatment related to cord blood transplantations. Major public and private banks facilitate cord blood units that are successfully used in the treatment of various form of cancer and genetic diseases.

By Region

North America cord blood banking market

Get more details on this report - Request Free Sample PDF

North America cord blood banking market is anticipated to reach USD 6.9 billion by 2025 on account of presence of large number of players operating in the country. Additionally, presence of large number of genetic disorders will further fuel the demand for cord blood cells market. Moreover, continuous efforts by researchers to explore new therapeutic applications of cord blood cells will spur the market demand.

Asia Pacific cord blood banking market is projected to register growth of 6.7% till 2025 owing to increasing awareness regarding the advantages of preservation of cord blood cells across the developing economies of India and China. These countries have great potential for growth driven by comparatively higher birth rate. Various market leaders are entering the developing nations to explore untapped opportunities, thus fostering the regional growth. 

Competitive landscape

Key companies operating in the global cord blood banking market are Singapore Cord Blood Bank, CBR Systems, ViaCord LLC, Cordlife, FamiCord, Cryo-Save, Americord, Global Cord Blood Corporation, LifeCell and Jeevan Stem Cell Foundation. Various strategies such as collaborations, acquisitions, mergers are undertaken by these players to strengthen market position.

Industry Background

Cord blood transplant can be traced back to the early 1990s when the first cord blood transplant was performed for treating T?cell leukemia. Since then, the technique underwent numerous advancements due to extensive R&D activities to explore new therapeutic implications. Currently cord blood is used for more than 80 therapeutic applications ranging from genetic disorders to metabolic disorders. In 2005, National Cord Blood Inventory (NCBI) was formed with the aim to increase the national supply of publicly donated cord blood units. Cord blood banking industry is set to grow swiftly in the developing economies such as India and China impelled by high birth rate and growing healthcare infrastructure. Major market participants are exploring the untapped opportunities to increase their market presence.

Recent industry developments:

  • In April 2019, FamiCord Group announced the agreement of future business cooperation with CelluGen Biotech (India). This agreement will assist to generate beneficial synergies for both the companies in the field of family-based stem cell banking and the development of new stem cell-based drugs
  • In September 2018, CryoSave announced the introduction of its new storage facility in Geneva. This new safe and secure sample storage BioBank in its state-of-the-art central laboratory ensures a capacity of cryopreservation for more than millions of samples thus, increasing its storage facilities.

Cord blood banking market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Market, by Type of Bank, 2014 – 2025 (USD Million)

  • Public
  • Private

Market, by Services, 2014 – 2025 (USD Million)

  • Processing
  • Storage
  • Others

Market, by Application, 2014 – 2025 (USD Million)

  • Cancer
  • Blood Disorders
  • Immuno-deficiency disorders
  • Metabolic disorders
  • Bone marrow failure syndrome
  • Others

Market, by End-use, 2014 – 2025 (USD Million)

  • Hospitals
  • Research institutes
  • Specialty clinics
  • Others

The above information is provided for the following regions/countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Belgium
  • Asia Pacific
    • China
    • Japan
    • Australia
    • Singapore
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • UAE


Frequently Asked Questions (FAQ) :

The market size of cord blood banking exceeded USD 16 billion in 2018.
The industry share of cord blood banking is expected to witness 5%+ CAGR from 2019 to 2025.

Premium Report Details

  • Published Date: Apr 2019
  • Pages: 161
  • Tables: 230
  • Charts / Figures: 9
  • Companies covered: 12
  • Countries covered: 17

Get a report that explains COVID-19 impact on this market

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X